FDA shows no love for Johnson & Johnson Xarelto blood thinner, rejects expanded use for 3rd time The FDA didn't show any love for Johnson & Johnson on Friday, Feb. 14, denying the pharmaceutical major's application for the expanded use of the anticoagulant drug Xarelto for the third time. by Randell Suba
China Launches World's Largest Electric Container Ship, Slashing 8,600 Pounds of Emissions per 100 Nautical Miles